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Abstract 
Background: People who use drugs are at a disproportionately higher risk of mental disorders due to prolonged 
exposure to psychosocial challenges. However, studies on mental health among people who use drugs in resource-
constrained countries are scarce. This study sheds light on the prevalence and correlates of psychological distress 
among people who use drugs in Cambodia.
Methods: We conducted this cross-sectional study in the capital city and 11 provinces in 2017. The Respondent 
Driven Sampling method was adapted to recruit 1677 people who used drugs for face-to-face interviews using a 
structured questionnaire. Psychological distress was measured using the General Health Questionnaire (GHQ-12). A 
total score of GHQ-12 > 2 indicated high psychological distress. We performed a multiple logistic regression analysis to 
identify factors associated with psychological distress.
Results: We included 1598 participants in the analyses, with a mean age of 28.6 years (SD = 7.8). Of the total, 42% 
had high psychological distress – 50% in women and 37% in men. The adjusted odds of having high psychological 
distress were significantly higher among participants who were 25–34 years old and 35 years and above, had been to 
a drug rehabilitation center, had been insulted by family members, and had been sexually harassed/abused by some-
one when they were growing up. The odds of having high psychological distress were significantly lower among 
participants who were male, lived in their own dwelling, reported injecting as the mode of the first drug use, and had 
someone taking care of them when they got sick.
Conclusions: This study documents a high prevalence of psychological distress among people who use drugs in 
Cambodia. Intervention programs that attempt to address mental health problems among people who use drugs in 
resource-limited settings should be gender- and age-sensitive and target more marginalized subpopulations. Mental 
health services can be integrated into HIV and harm-reduction programs for people who use drugs.
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Background
In 2017, the global estimate of the number of people who 
use drugs, including people who inject drugs, aged 15–64 
were 271 million [1], equivalent to about 5% of the world 
population of the same age. Of them, about 35 million 
(13%) suffered from drug-use disorders, which resulted 
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Disability-Adjusted Life Years (DALYs) [1, 2]. Therefore, 
drug use is recognized as one of the major global public 
health concerns. However, the availability of and access 
to treatment services among people with drug use dis-
orders remain limited globally. Only one in seven people 
who use drugs receive the treatment each year [1].
Existing studies show that the comorbidity between 
drug-use disorders and mental health problems is com-
mon among people who use drugs. Moreover, people 
who use drugs without drug-use disorders are also at 
increased risk of mental health problems [3–10]. Sub-
stance use disorders have been found to occur in tandem 
with anxiety disorders including generalized anxiety dis-
order, panic disorder, and post-traumatic stress disorder 
[11–14]; mental disorders including depression and bipo-
lar disorder [8, 11–13]; attention deficit hyperactivity dis-
order [12, 14]; and antisocial personality disorder [15].
The relationship between mental health and risky drug 
use, particularly intravenous drug use and unsafe sexual 
practices, has been well documented in previous stud-
ies. People who use drugs with poor mental health, such 
as severe depressive symptoms, are more likely to adopt 
unsafe injection practices such as sharing needles and 
syringes [16–18]. Previous studies have also reported that 
people who use drugs with mental health problems were 
more likely to have more sexual partners and engage in 
frequent condomless sexual intercourse than those with-
out mental health problems [19, 20]. These risky behav-
iors are associated with a higher risk of acquiring human 
immunodeficiency virus (HIV) [21].
Mental health problems of people who use drugs are 
a significant public health concern as it co-occurs with 
drug use disorders and mediates other viral infections 
such as HIV and hepatitis C virus (HCV) [22–24]. There-
fore, addressing risk factors associated with mental health 
problems among people who use drugs would reduce the 
disease burden of drug use disorders and HIV and HCV 
infections among people who use drugs. Previous stud-
ies have documented drug use behaviors and experiences 
such as duration [25], frequency [21], overdose [26–28], 
and drug rehabilitation [21, 25] as associated risk factors 
of psychological distress. Exposure to violence, such as 
stigma and discrimination and sexual assault, and lack 
of social support, such as family intimacy and adaptabil-
ity, have also been predictors of psychological distress 
among people who use drugs [26, 29–34].
In Cambodia, the latest estimated number of people 
who use drugs aged 18 years and above in 2017 was nota-
bly large at around 22,374 people [16]. Previous studies 
show that psychological distress is common among Cam-
bodian people who use drugs [17, 21, 25]. Also, access to 
psychological support, such as services provided in drop-
in centers by community-based organizations, is limited 
[16]. In 2017, 90,672 people received mental health treat-
ment within public health facilities, with approximately 
5% reporting that their mental health condition was 
driven by substance use [35]. Our previous study showed 
that adverse childhood experiences (ACEs) were com-
mon and associated with psychological distress among 
people who use drugs in Phnom Penh [21]. Despite the 
common mental health problems and limited access to 
care among people who use drugs, studies on these issues 
remain scarce, preventing it from gaining policy and stra-
tegic attention.
To our knowledge, two studies on the mental health of 
people who use drugs have been conducted in Cambodia 
[21, 25]. Yi et  al. included only people who inject drugs 
living in the capital city of Phnom Penh, while Heng et al. 
used data from the national survey conducted in 2012 
and focused primarily on the relationship between men-
tal health outcomes and history of drug rehabilitation. In 
this study, we used data from the most recent national 
integrated biological and behavioral survey in 2017 to 
examine the prevalence and correlates of psychological 
distress among people who use drugs in Cambodia.
Methods
Study design and setting
We conducted this cross-sectional study in Cambodia 
in 2017 in the capital city and 11 provinces. A feasibility 
assessment was conducted before selecting the 12 sites, 
which consisted of 21 operational districts with a high 
burden of HIV and a large population of people who use 
drugs. People who use drugs were defined as people who 
have used any illicit drugs, as stated in the Cambodian 
Law on Control of Drugs, in the past 12 months [36].
Eligibility criteria
To be eligible for the survey, an individual must: (1) be at 
least 18  years old, (2) have a predetermined study cou-
pon, (3) never participate in this survey earlier, (4) meet 
the definition of people who use drugs, and (5) be able 
and willing to provide written informed consent to par-
ticipate in the survey. Details of the survey have been 
published elsewhere [37–39].
Sampling procedure
We adapted the Respondent-Driven Sampling (RDS) 
method to recruit the study participants due to the hard-
to-reach nature of people who use drugs. The sampling 
procedure included five steps. Initially, we sought sup-
port from local NGOs in the selected 21 operational 
districts to obtain four seeds with a good connection 
with people who use drugs in each operational district. 
A personal identification number was then assigned to 
each seed after receiving written informed consent from 
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the participant. Next, we provided three coupons to each 
seed for referring three other people who use drugs to 
the study. Seeds received US$2 for a successful referral 
and were expected to refer three to six peers. New seeds 
would be selected when the recruitment tree had dried 
up. Finally, participants recruited for the study were 
invited to become seeds allowing them to recruit other 
people who use drugs from their networks.
Figure  1 shows the flow chart of the sample selec-
tion. The survey included 1677 participants. We finally 
included 1598 participants in the multiple logistic regres-
sion analysis after dropping 79 observations with missing 
data on the model variables.
Data collection training
The interviews were conducted by formally trained coun-
selors from HIV voluntary counseling and testing centers 
in the respective province. Data collection teams received 
3  day training on data collection procedures, informed 
consent process, data collection tools, interview tech-
niques, participants’ privacy and confidentiality protec-
tion, and data quality assurance.
Variables and measurements
A structured questionnaire was developed based on 
standardized and validated tools adapted from previous 
studies on mental health among HIV key populations, 
including people who use drugs [21, 40–42]. We also 
conducted a questionnaire validation workshop par-
ticipated by representatives from communities, NGOs, 
development partners, and national programs working 
on HIV and harm reduction in Cambodia. The question-
naire was piloted with 20 people who use drugs residing 
in Phnom Penh. The questionnaire collected information 
on sociodemographic characteristics, drug use behaviors, 
sexual behaviors, HIV and other sexually transmitted 
infections (STIs), other substance use, adverse childhood 
experiences, and psychological distress.
Esmated populaon size of people who 
use drugs in Cambodia (n= 14300)
Minimum required sample size 
(n= 1680) 
Sample size in the naonal Integrated 
Biological and Behavioral Survey  
(n= 1677) 
Final sample in the mulple logisc 
regression model (n= 1598) 




Dropping parcipants with missing 
data of variables in the mulple 
logisc regression model (n= 79)
Fig. 1 Flow chart of sample selection
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Sociodemographic characteristics included age (18–24, 
25–34, 35 and older), sex (male, female), type of com-
munity (urban, rural), years of formal schooling attained 
(0–6, 7–9, 10 + years), average monthly income earned 
in the past 6  months (< 100, 100–199, 200 + USD), pri-
mary occupation (entertainment workers, office workers, 
laborer/farmer, unemployed, other), and living arrange-
ment (living with family/relatives, living with friends, liv-
ing in own dwelling, living on the streets, other).
The information on drug use included types of illicit 
drugs most commonly used and use frequency in the past 
3 months. We also collected information regarding other 
substance use (i.e., alcohol drinking and binge drinking, 
cigarette smoking) and exposure to community-based 
HIV, harm reduction, and other related services in the 
past 6 months.
To measure HIV risks, we asked participants about 
their sexual behaviors in the past 3 months. The informa-
tion included the number of sexual partners and condom 
use with commercial (defined as partners with whom the 
participant had sex in exchange for money or gifts) and 
non-commercial partners. We also collected information 
on HIV testing history, STI symptoms, and care-seeking 
behaviors for the symptoms in the past 3 months.
We adapted five ACE questions from the brief screen-
ing version of the Childhood Traumatic Questionnaire 
[43]. The items collected information on physical abuse, 
emotional abuse, sexual abuse, physical neglect, and 
emotional neglect. All five questions were close-ended, 
where respondents chose between zero (No) and one 
(Yes) to describe their ACEs.
We assessed psychological distress, the study’s out-
come of interest, using the General Health Questionnaire 
(GHQ-12) [44]. A four-point Likert-type scale, which 
varied from “0 = less than usual” to “3 = much more than 
usual,” was applied to each question [44, 45]. A dichoto-
mous variable of “0 = low psychological distress” and 
“1 = high psychological distress” was developed based on 
the GHQ-12 guide [45]. The four-point Likert-like scale 
was re-coded using a “0–0-1–1” method to eliminate bias 
[46]. The mean of the newly derived score’s sum was used 
as a cut-off to define participants with high (GHQ-12 > 2) 
and low (GHQ-12 ≤ 2) psychological distress [44]. Cron-
bach’s alpha of the scale in this study was 0.88, confirm-
ing good reliability [47].
Statistical analyses
Stata (StataCorp LP, version 14.2) was used for data 
analyses in this study. We compared sociodemographic 
characteristics, substance use, sexual behaviors, and 
ACEs of participants with low psychological distress 
(GHQ-12 ≤ 2) to those of participants with high psycho-
logical distress (GHQ-12 > 2). We used the Chi-square 
test (or Fisher’s exact test when the expected cell count 
was smaller than five) for categorical variables and Stu-
dent’s t-test (or Mann–Whitney test when a variable 
was not normally distributed) for continuous variables. 
A multiple logistic regression model was constructed to 
identify factors associated with psychological distress. 
We included age and sex regardless of their statistical 
significance level and other variables associated with 
psychological distress in bivariate analyses at a level of 
p-value < 0.05 in the multiple logistic regression model. 
We obtained crude odds ratios (OR) and adjusted odds 
ratios (AOR) of the associations and presented with 95% 
confidence intervals (CIs) and p-values.
Ethical considerations
This study received ethical approval from the National 
Ethics Committee for Health Research (NECHR) of the 
Ministry of Health in Cambodia (No. 420 NECHR). Par-
ticipation in the study was voluntary, and all participants 
provided written informed consent. We protected par-
ticipants’ privacy and confidentiality by collecting data 
in a private room and removing personal identifiers from 
research documents.
Results
This study included 1598 people who use drugs, after 
excluding 79 participants with missing data. As shown 
in Table  S1 (Additional file  1), no significant differ-
ence was found in the comparison of sociodemo-
graphic characteristics and psychological distress of 
the included and excluded samples. The participants 
included in the analyses had an average age of 28.6 years 
(SD = 7.8), average years of formal schooling completed 
of 6.0  years (SD = 3.9), and a median monthly income 
in the past 6  months of US$100.0 (interquartile range 
[IQR]: 60–150). People who inject drugs constituted 19% 
of the study sample. Around one-third of the partici-
pants resided in Phnom Penh, while 16% lived in Banteay 
Meanchey and 11% in Battambang province, which bor-
der Thailand. Of the total sample, 42% had high psycho-
logical distress – 50% in women and 37% in men.
The participants’ sociodemographic characteristics, 
substance use, sexual behaviors, and adverse childhood 
experiences are respectively presented in Tables S2, S3, 
S4, and S5 of the Additional file 1. In brief, approximately 
63% of the participants were male, and 89% lived in an 
urban setting. More than half (53%) had primary or no 
formal education, and 66% were 25 years of age or older. 
The majority (95%) were in the Khmer ethnic group, and 
46% were never married. The proportion of participants 
having been to a prison and a drug rehabilitation center 
in the past 12 months was 11 and 16%, respectively. More 
than half (55%) reported having been slapped, kicked, or 
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received physical punishment from a family member or a 
guardian when they were growing up. About half (51%) 
reported having been insulted by family members or 
guardians, and 22% reported having been sexually har-
assed or abused when they were growing up.
Factors associated with psychological distress
Results of bivariate and multiple logistic regression 
analyses are presented in Table  1. After adjustment for 
other covariates in the model, the odds of having high 
psychological distress was significantly higher among 
participants who were 25–34  years old (AOR 1.30, 95% 
CI 1.01–1.70) and 35  years and older (AOR 1.68, 95% 
CI 1.19–2.35), had been to a drug rehabilitation center 
(AOR 2.06, 95% CI 1.48–2.86), had been insulted by fam-
ily members (AOR 2.09, 95% CI 1.62–2.70), and had been 
sexually harassed or abused by someone (AOR 1.80, 95% 
CI 1.38–2.36). The odds of having high psychological 
distress was significantly lower among participants who 
were male (AOR 0.53, 95% CI 0.41–0.69), lived in own 
dwelling (AOR 0.56, 95% CI 0.41–0.77), reported inject-
ing as the mode of the first drug use (AOR 0.56, 95% CI 
0.34–0.91), and had someone taking care of them when 
they got sick when they were growing up (AOR 0.68, 95% 
CI 0.47–0.99).
Discussion
This study provides evidence of the prevalence and fac-
tors associated with psychological distress, measured by 
GHQ-12, among people who use drugs in a resource-
constrained country. We found that the prevalence of 
psychological distress among people who use drugs in 
this study was 42%, which was similar to the finding in 
our previous study conducted in 2014 using the same 
measure of psychological distress among people who 
inject drugs in the capital city of Phnom Penh [21].
Sociodemographic factors
Our findings suggested that male people who use drugs 
were less likely to have high psychological distress 
than their female counterparts. This finding is consist-
ent with the results shown in previous studies [21, 25, 
48]. In Taiwan, female people who use drugs were more 
likely to have suicidal thoughts than their male counter-
parts, resulting in more psychiatric illnesses than men 
[48]. Finding in our setting could be explained by the 
differences in education level, type of occupation, and 
level of stigma and discrimination between male and 
female participants. In our bivariate analyses, individu-
als with upper secondary education were twice as less 
distressed as those with primary or no education. Only 
7% of female participants had upper secondary educa-
tion compared to 25% of men. We also found that 43% 
of female participants in this study worked in the enter-
tainment sector compared to only 4% of men. Being 
female entertainment workers could be an underlying 
factor because a previous study among female enter-
tainment workers in Cambodia showed a high preva-
lence of gender-based violence at work and its positive 
association with psychological distress [49]. This result 
implies that interventions to address mental health 
among people who use drugs should be gender-sensi-
tive and focused on subpopulations with lower educa-
tion and in occupations that expose them to underlying 
risks.
People who use drugs aged 25 years and older were sig-
nificantly more likely to have high psychological distress 
than their younger peers aged 18 to 24. This finding cor-
roborates with findings in a previous study in Cambodia 
[25]. In this study, we found that participants aged 25 and 
older were more likely to have suicidal thoughts and to 
drink alcohol four times or more per week in the past 
3 months than their younger counterparts (aged 18–24). 
The co-occurrence of substance use and mental illness 
among people who use drugs [11–14] and the association 
between suicidal thoughts and mental health [3, 21] has 
also been documented in previous studies. An institu-
tionalized experience, such as being sent to a drug reha-
bilitation center, could be another factor in this setting. 
In this study, around one in five of participants in the age 
groups of 25–34 years and 35 years and older had been 
sent to rehabilitation centers compared with one in ten 
among participants aged 18–24 years. In bivariate analy-
ses, individuals with rehabilitation experience were more 
than twice more likely to have psychological distress than 
those without the experience. This result suggests that 
multi-faceted (e.g., the trauma from being institutional-
ized, multiple substance abuse) interventions should tar-
get the elder subpopulation of people who use drugs.
We found that people who use drugs living in their 
own dwelling were less distressed than those living 
with family. Our descriptive data showed that around 
40% of the participants living in own dwelling and hav-
ing been exposed to physical abuse during childhood 
exhibited psychological distress compared to 54% of 
those living with families and having had similar ACEs. 
Therefore, ACEs could have been a driver of the choice 
of living arrangement. It should be noted that marriage 
and cohabitation might have mediated the association as 
close to two-thirds of the participants living in their own 
dwelling were married and cohabited. Breaking free from 
the past ACEs with family and forming their independent 
cohabitation with a spouse, people who use drugs living 
in their own dwelling were less psychologically distressed 
than those living with family. This finding highlights the 
need for interventions that enhance families’ roles in 
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Table 1 Factors associated with  psychological distress among  people who use drugs in  bivariate and  multivariable 
logistic regression analyses (n = 1598)
Variables in the model GHQ-12 ≤ 2 (n = 927) GHQ-12 > 2 (n = 671) Bivariate logistic regression Multiple logistic regression
n (%) n (%) OR (95% CI) AOR (95% CI)
Sex
 Female 298 (32.1) 298 (44.4) Reference Reference
 Male 629 (67.9) 373 (55.6) 0.59 (0.48–0.73)*** 0.54 (0.41–0.69)***
Age group
  < 25 351 (37.8) 200 (29.8) Reference Reference
 25–34 380 (41.0) 300 (44.7) 1.38 (1.10–1.74)** 1.31 (1.00–1.72)*
  ≥ 35 196 (21.2) 171 (25.5) 1.53 (1.17–2.00)** 1.65 (1.18–2.32)**
Current marital status
 Married 349 (37.6) 251 (37.4) Reference Reference
 Never married 448 (48.3) 287 (42.8) 1.42 (1.06–1.90)* 1.01 (0.76–1.33)
 Divorced/separated 130 (14.1) 133 (19.8) 0.89 (0.71–1.11) 1.08 (0.78–1.49)
Level of formal education completed
 Primary education or none (0–6) 472 (50.9) 382 (56.9) Reference Reference
 Lower secondary education (7–9) 265 (28.6) 182 (27.1) 0.84 (0.67–1.07) 1.06 (0.82–1.37)
 Upper secondary or higher (≥ 10) 190 (20.5) 107 (15.9) 0.69 (0.53–0.91)** 0.90 (0.66–1.23)
Type of living arrangements
 With family/relatives 438 (47.2) 314 (46.8) Reference Reference
 On the streets 87 (9.4) 72 (10.7) 1.15 (0.82–1.63) 0.70 (0.46–1.06)
 In own dwelling 230 (24.8) 131 (19.5) 0.79 (0.61–1.03) 0.56 (0.41–0.76)***
 With friends 94 (10.2) 72 (10.8) 1.07 (0.76–1.50) 0.88 (0.61–1.27)
 Others 78 (8.4) 82 (12.2) 1.47 (1.04–2.06)*** 1.11 (0.76–1.63)
Duration of drug use
  ≤ 2 years 584 (63.0) 380 (56.6) Reference Reference
 3–5 years 187 (20.2) 147 (21.9) 1.21 (0.94–1.55) 1.19 (0.90–1.57)
 6–9 years 54 (5.8) 44 (6.6) 1.25 (0.82–1.90) 1.07 (0.67–1.71)
  ≥ 10 years 102 (11.0) 100 (14.9) 1.51 (1.11–2.04)*** 1.11 (0.75–1.63)
Had been sent to a drug rehabilitation center
 No 821 (88.6) 521 (77.6) Reference Reference
 Yes 106 (11.4) 150 (22.4) 2.23 (1.70–2.93)*** 2.05 (1.47–2.85)***
Injection as mode of first drug use
 No 838 (90.4) 609 (90.8) Reference Reference
 Yes 89 (9.6) 62 (9.2) 0.95 (0.68–1.35) 0.57 (0.35–0.92)*
Had been sent to prison in the past 12 months
 No 834 (90.0) 583 (86.9) Reference Reference
 Yes 93 (10.0) 88 (13.1) 1.35 (0.99–1.84) 0.99 (0.69–1.43)
Had been slapped, kicked by parents/guardians
 No 477 (51.5) 250 (37.3) Reference Reference
 Yes 450 (48.5) 421 (62.7) 1.78 (1.45–2.18)*** 1.13 (0.88–1.46)
Had been insulted by family members
 No 535 (57.7) 245 (36.5) Reference Reference
 Yes 392 (42.3) 426 (63.5) 2.37 (1.93–2.91)*** 2.10 (1.63–2.71)***
Had been sexually harassed/abused by someone
 No 780 (84.1) 468 (69.7) Reference Reference
 Yes 147 (15.8) 203 (30.3) 2.3 (1.81–2.93)*** 1.80 (1.38–2.35)***
Had someone taking care of them when they got sick
 No 86 (9.3) 83 (12.4) Reference Reference
 Yes 841 (90.7) 588 (87.6) 0.72 (0.53–0.99)* 0.69 (0.48–1.01)*
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supporting behavioral changes in people who use drugs 
living with their families [50].
The finding that people who use drugs who had been 
to a drug rehabilitation center had more psychological 
distress than those who had never been to the center 
confirmed findings in previous studies in Cambodia 
[21, 25]. This finding suggests that the drug rehabilita-
tion centers’ role remained counterproductive 5  years 
later. The low overall quality of life and the health of 
people who use drugs with a history of rehabilitation 
could be the underlying drivers of psychological dis-
tress. However, adverse experience in rehabilitation 
centers remained a valid explanation, as indicated 
in another study in 2012 [25]. A recent investigation 
involving people who use drugs from two rehabilita-
tion centers and relevant stakeholders in Phnom Penh 
suggested that there was evidence of physical abuse, 
inadequately-equipped facilities, absence of medical 
assistance to tackle withdrawal symptoms, non-exist-
ent counseling services, and absence of proper medical 
supervision [51]. Similar accounts had also been docu-
mented in China [52], Taiwan [48], and Vietnam [53]. 
It is important to note that living with HIV while in 
the rehabilitation centers might have compounded the 
participants’ psychological distress. A previous study in 
China reported a lack of ART access in rehabilitation 
centers among people who inject drugs living with HIV 
[52].
Moreover, the existing evidence showed that HIV-pos-
itive status is directly linked with mental disorders via 
neuro-biological mechanisms [54]. HIV-positive status is 
also indirectly related to mental disorders through stigma 
and discrimination [55], particularly among people living 
with HIV without access to antiretroviral therapy (ART) 
and insufficient or late ART receipt [56]. This result 
appeals to the policymakers to review the current roles 
and operation of drug rehabilitation centers and calls for 
adopting an alternative community-based program, as 
suggested in previous studies [25, 57].
Adverse Childhood Experiences (ACEs)
The participants who had been insulted by family 
members or guardians or sexually harassed or abused 
when growing up exhibited a higher level of psycho-
logical distress than those who had not. On the other 
hand, the participants who experienced care provided 
by someone when they got sick were less psychologi-
cally distressed than those who did not. These findings 
are consistent with studies in the United States [58] 
and Cambodia [21]. In their systematic review, De Ven-
ter et  al. showed that people who use drugs who had 
experienced ACEs exhibited symptoms or diagnoses of 
depressive and anxiety disorders [59]. The association’s 
pathway likely ran from ACEs to entry to drug use, and 
later, to psychological distress. Another study showed 
that people aged 14 and above in California with a 
higher ACE score were about two to four times more 
likely to initiate drug use than people with a lower ACE 
score [60]. Another possible pathway could have been 
from ACEs to low self-esteem or self-regards, drug use, 
and, finally, psychological distress. A study in Japan 
showed that female juvenile offenders who reported 
ACEs tended to have low self-esteem [61]. Another 
study in Iran showed that participants who had low 
self-esteem had a tendency towards drug addiction 
[62]. In Cambodia’s setting, no research has empirically 
explored the association between ACEs and entry to 
drug use among the adult population, suggesting that 
AOR adjusted odds ratio, CI confidence interval, GHQ General Health Questionnaire, OR odds ratio
Psychological distress was measured using the General Health Questionnaire (GHQ-12), and a total score of GHQ-12 > 2 was used to define high psychological distress
*p < 0.05; **p < 0.01, ***p < 0.001
Table 1 (continued)
Variables in the model GHQ-12 ≤ 2 (n = 927) GHQ-12 > 2 (n = 671) Bivariate logistic regression Multiple logistic regression
n (%) n (%) OR (95% CI) AOR (95% CI)
Had emotional support from family members
 No 124 (13.4) 111 (16.5) Reference Reference
 Yes 803 (86.6) 560 (83.5) 0.78 (0.59–1.03) 1.19 (0.86–1.65)
Injected drugs in the past 12 months
 No 769 (83.0) 531 (79.1) Reference Reference
 Yes 158 (17.0) 140 (20.9) 1.28 (0.99–1.65) 1.40 (0.95–2.06)
Current HIV status
 Negative 588 (63.4) 430 (64.1) Reference Reference
 Positive 31 (3.3) 47 (7.0) 2.07 (1.29–3.32)** 1.63 (0.98–2.71)
 Do not know 308 (33.3 194 (28.9) 0.86 (0.69–1.07) 1.10 (0.87–1.40)
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future studies on this topic are warranted. Neverthe-
less, since ACEs are risk factors of psychological dis-
tress among adult people who use drugs, it is essential 
that these ACEs are identified and prevented [63].
Limitations of the study
Despite several strengths, the limitations of this study 
should be noted. First, causal inference from our mul-
tiple logistic regression analysis could not be made as 
we did not address endogeneity (e.g., omitted variable 
bias or reverse causality) of each independent variable. 
Thus, the results should be interpreted as the associa-
tion between the dependent and independent variables. 
Second, since our measure of psychological distress was 
constructed based on self-reported responses to the 
GHQ-12 questionnaire but not a performance-based 
psychological measure, our association results could be 
biased due to social desirability and recall bias. Third, 
the study findings’ generalizability may be limited 
because the study targeted provinces with a heavy HIV 
and drug use burden to obtain a large sample. Further-
more, the participants likely self-selected into the study 
as they could have been motivated by the incentive 
(token) provided through the RDS method.
Conclusions
This study documents a high prevalence of and risk fac-
tors associated with psychological distress among people 
who use drugs in Cambodia. Risk factors significantly 
associated with psychological distress among people 
who use drugs in this study included sex, age, history of 
drug rehabilitation, and ACEs. Women showed higher 
psychological distress than men, while people aged 
25  years and older also exhibited higher psychologi-
cal distress than people aged 18–24. Our results on the 
counterproductive role of drug rehabilitation and the 
negative effect of ACEs on the psychological distress of 
people who use drugs also corroborated with findings 
in earlier studies. Therefore, intervention programs that 
attempt to address mental health among people who 
use drugs should be gender- and age-sensitive. The pro-
grams should be tailored to more vulnerable and mar-
ginalized subpopulations and individuals with a history 
of ACEs and drug rehabilitation. Importantly, integrat-
ing mental health services into HIV and harm-reduction 
programs for people who use drugs across all health care 
system levels is a promising alternative to tackle men-
tal health problems among this vulnerable population. 
Community-based rehabilitation or treatment programs 
could be an alternative to rehabilitation centers, given 
the centers’ counterproductive roles.
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